This project brings together critical mass in the UK of expertise in paediatric formulation development from industrial partners, CMO/SMEs and academic experts as a Consortium to develop a novel suite of predictive analytical and in silico techniques.
The tools developed by the Consortium will be used to provide a step-change in speed, cost and quality benefits for paediatric formulation development whilst ensuring a greater probability of regulatory and technical success in an increasingly challenging environment.
An objective of the Consortium is to establish the UK as the premier centre for development of paediatric medicines, increasing external and internal investment into this area, boosting the UK science base.
An objective of the Consortium is to establish the UK as the premier centre for development of paediatric medicines, increasing external and internal investment into this area, boosting the UK science base.
